Acurx Pharmaceuticals (ACXP)

Acurx Pharmaceuticals (ACXP) Financial Statements


Acurx Pharmaceuticals Financial Overview

Acurx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.103; its P/E ratio is -2.63; Acurx Pharmaceuticals is scheduled to report earnings on August 14, 2023, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -2.90M$ -3.26M$ -3.54M$ -2.62M$ -2.67M
EBITDA$ -2.90M$ -3.26M$ -3.54M$ -2.62M$ -2.67M
Net Income Common Stockholders$ -2.90M$ -3.26M$ -3.54M$ -2.62M$ -2.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.20M$ 9.11M$ 10.61M$ 9.09M$ 11.08M
Total Assets$ 7.41M$ 9.38M$ 10.95M$ 9.26M$ 11.32M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.20M$ -9.11M$ -10.61M$ -9.09M$ -11.08M
Total Liabilities$ 2.07M$ 2.06M$ 1.18M$ 473.88K$ 633.03K
Stockholders Equity$ 5.31M$ 7.32M$ 9.76M$ 8.79M$ 10.69M
Cash Flow-
Free Cash Flow$ -1.93M$ -1.50M$ -2.18M$ -1.99M$ -1.88M
Operating Cash Flow$ -1.93M$ -1.50M$ -2.18M$ -1.99M$ -1.88M
Investing Cash Flow-----
Financing Cash Flow-$ -1.00$ 3.70M--
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Acurx Pharmaceuticals Debt to Assets

Acurx Pharmaceuticals Cash Flow

Acurx Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis